general-medicine surgery orthopaedics
Caprini VTE Risk Assessment
Assesses VTE risk in surgical patients. Guides mechanical and pharmacological prophylaxis decisions.
Used in: Venous Thromboembolism (DVT & PE)
Score interpretation
Low VTE risk
→ Early ambulation; mechanical compression stockings; no pharmacological prophylaxis routine
Moderate VTE risk
→ LMWH (enoxaparin 20-40mg OD) or UFH; TED stockings; pneumatic compression
High VTE risk
→ LMWH for 28 days post-op (extended prophylaxis); IPC devices; balance with bleeding risk
Interpretation bands for the Caprini Score. Apply clinical judgement and local guidance.
References
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- HERDOO2 Rule for Discontinuing Anticoagulation in Unprovoked VTE · Venous Thromboembolism
- RIETE Score for Bleeding Risk in VTE · Venous Thromboembolism
- Wells Criteria for PE · Venous Thromboembolism
- Wells Criteria for DVT · Venous Thromboembolism
- PERC Rule for PE · Venous Thromboembolism
- Revised Geneva Score for PE · Venous Thromboembolism
Drugs
- Cefuroxime · Second-Generation Cephalosporin — Respiratory / Surgical Prophylaxis
- Enoxaparin (VTE in Pregnancy) · Low Molecular Weight Heparin (LMWH) — VTE Prophylaxis/Treatment
- Enoxaparin (Orthopaedic VTE Prophylaxis) · Low Molecular Weight Heparin (LMWH)
- Cefazolin · First-Generation Cephalosporin (Surgical Prophylaxis)
- Palivizumab · RSV Prophylaxis — Monthly Monoclonal Antibody (High-Risk Infants)
- Rivaroxaban (PE Treatment) · Venous Thromboembolism
Pathways
- Falls Assessment in Older Adults · NICE CG161 2013
- Anaemia Investigation · BSH / NICE
- Lower Respiratory Tract Infection (Primary Care) · NICE NG138 / NICE antimicrobial guidance
- Hypertension Management · NICE NG136 2019
- Major Trauma — Primary Survey (ATLS) · ATLS 10th Edition; JRCALC; NICE NG39
- Major Haemorrhage / Massive Transfusion · BCSH; RCOA; RCEM; RCS — BCSH Guidelines
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.